EMERALD ADVISERS, LLC - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q1 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q2 2016$8,019,000
-36.0%
278,252
-28.9%
0.39%
-36.7%
Q1 2016$12,523,000
+10.2%
391,106
+47.2%
0.61%
+13.8%
Q4 2015$11,360,000265,6660.54%
Other shareholders
IMPAX LABORATORIES INC shareholders Q1 2016
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,032,187$24,463,0008.84%
Asymmetry Capital Management, L.P. 164,156$3,890,0006.76%
Hound Partners 6,204,588$147,049,0003.96%
Sivik Global Healthcare LLC 130,000$3,081,0001.55%
Tradewinds Global Investors, LLC 49,661$1,177,0001.45%
SECTOR GAMMA AS 409,964$7,318,0001.28%
Orbimed Advisors 3,787,500$89,764,0001.02%
Iguana Healthcare Management, LLC 200,000$4,740,0000.84%
Seven Bridges Advisors LLC 37,409$887,0000.79%
Penn Capital Management Company, LLC 454,597$10,808,0000.73%
View complete list of IMPAX LABORATORIES INC shareholders